The novel coronavirus (COVID-19) pandemic that emerged from Wuhan city in December 2019 overwhelmed health systems and paralyzed economies around the world. It became the most important public health challenge facing mankind since the 1918 Spanish flu pandemic. Various theoretical and empirical approaches have been designed and used to gain insight into the transmission dynamics and control of the pandemic. This study presents a primer for formulating, analysing and simulating mathematical models for understanding the dynamics of COVID-19. Specifically, we introduce simple compartmental, Kermack-McKendrick-type epidemic models with homogeneously- and heterogeneously-mixed populations, an endemic model for assessing the potential population-level impact of a hypothetical COVID-19 vaccine. We illustrate how some basic non-pharmaceutical interventions against COVID-19 can be incorporated into the epidemic model. A brief overview of other kinds of models that have been used to study the dynamics of COVID-19, such as agent-based, network and statistical models, is also presented. Possible extensions of the basic model, as well as open challenges associated with the formulation and theoretical analysis of models for COVID-19 dynamics, are suggested.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786036 | PMC |
http://dx.doi.org/10.1016/j.idm.2020.11.005 | DOI Listing |
J Clin Epidemiol
December 2024
Department of Internal Medicine, Section of Geriatrics and Gerontology, Leiden University Medical Center, Leiden, The Netherlands.
Objective: During the COVID-19 pandemic, dynamic factors such as governmental policies, improved treatment and prevention options and viral mutations changed the incidence of outcomes and possibly changed the relation between predictors and outcomes. The aim of the present study was to assess whether the dynamic context of the pandemic influenced the predictive performance of mortality predictions over time in older patients hospitalised for COVID-19.
Study Design And Setting: The COVID-OLD study, a multicentre cohort study in the Netherlands, included COVID-19 patients aged 70 years and older hospitalised during the first (early 2020), second (late 2020), third (late 2021) or fourth wave (early 2022).
Accid Anal Prev
December 2024
Global Data Insights & Analytics, Ford Motor Company, United States. Electronic address:
Police crash reports have traditionally been the primary data source for research and development projects aimed at improving traffic safety. However, there are important limitations of such data, particularly the relative infrequency of crashes on a site-by-site basis in many contexts. Crash analyses often require multiple years of data and the use of such data for short-term evaluations creates challenges.
View Article and Find Full Text PDFWater Res
December 2024
Department of Environmental Science and Engineering, University of Science and Technology of China, Hefei 230026, China. Electronic address:
Wastewater surveillance programs based at wastewater treatment plants (WWTPs) have been widely implemented, becoming a crucial measure for public health. Recently, the scope of monitoring has expanded from influent wastewater to include primary settled solids and activated sludge. The effectiveness of monitoring primary settled solids has been widely validated, but the suitability of activated sludge as a monitoring target remains unclear.
View Article and Find Full Text PDFAim: Study the effectiveness of Cytoflavin in the medical rehabilitation of elderly and senile patients after pneumonia associated with a new coronavirus infection (COVID-19) at the outpatient stage.
Materials And Methods: A prospective observational randomized study involving 66 patients (45 women and 21 men, average age 66.5±5.
Ter Arkh
December 2024
Kirov Military Medical Academy.
Aim: To evaluate the efficacy of the antiviral drug riamilovir (trade name - «Triazavirin») for the prevention of SARS-CoV-2 infection (COVID-19) and other acute respiratory viral infections in young people from organized groups.
Materials And Methods: The study involved 386 individuals aged 18-22 years: 199 received riamilovir at a daily dose of 250 mg for 15 days, while 187 did not receive prophylactic drugs. For 30 days, disease occurrence was monitored among volunteers.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!